Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00602355 · ClinicalTrials.gov registry record · Phase 2
Effectiveness of Sertraline Alone and Interpersonal Psychotherapy Alone in Treating Women With Postpartum Depression
A Phase 2 study of Depression, Postpartum, sponsored by Women and Infants Hospital of Rhode Island.
- Completed
- Registry status
- Phase 2
- Development phase
- 162
- Enrollment target
- 2
- Study locations
NCT00602355: Completed Phase 2 study of Depression, Postpartum, sponsored by Women and Infants Hospital of Rhode Island.
NCT00602355 is a Phase 2 study of Depression, Postpartum that has completed, run by Women and Infants Hospital of Rhode Island. The registered enrollment target is 162 participants, roughly in line with the 153-participant average among 15 other Depression, Postpartum trials with a reported enrollment target. The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00602355, a Phase 2 study of Depression, Postpartum, has completed, sponsored by Women and Infants Hospital of Rhode Island.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 162 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study will evaluate the effectiveness of antidepressant medication alone and interpersonal psychotherapy alone in treating women with postpartum depression.
Primary Outcome
Measure total ranges from 0 to 50, with lower scores indicating better outcomes.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Sertraline
- BEHAVIORAL Interpersonal psychotherapy (IPT)
- BEHAVIORAL Clinical management
- BEHAVIORAL Mothercrafting
Study Locations (2)
Iowa
- University of Iowa - Iowa City
Rhode Island
- Women and Infants Hospital - Providence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 162 participants |
| Start Date | 2008-02 |
| Est. Completion | 2014-07 |
| Phase | Phase 2 |
What the finished NCT00602355 record still lists
NCT00602355 is an interventional study that assigns participants to a tested intervention. The registered 162 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 153-participant average among 15 other Depression, Postpartum trials with a reported enrollment target.
The record links to 1 condition, with Depression, Postpartum appearing as the primary indexed condition, and to 5 interventions - of which Placebo is the first listed.
NCT00602355 reports a single indexed study location in Iowa, Rhode Island.
Frequently Asked Questions
What is clinical trial NCT00602355 about?
NCT00602355 is a clinical study titled "Effectiveness of Sertraline Alone and Interpersonal Psychotherapy Alone in Treating Women With Postpartum Depression". This study will evaluate the effectiveness of antidepressant medication alone and interpersonal psychotherapy alone in treating women with postpartum depression.
What is the current status of trial NCT00602355?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 162 participants. The study started on 2008-02. Estimated completion is 2014-07.
What conditions does trial NCT00602355 study?
This clinical trial studies the following conditions: Depression, Postpartum.
What interventions are being tested in trial NCT00602355?
The interventions under investigation include: Placebo (DRUG), Sertraline (DRUG), Interpersonal psychotherapy (IPT) (BEHAVIORAL), Clinical management (BEHAVIORAL), Mothercrafting (BEHAVIORAL).
Who is sponsoring clinical trial NCT00602355?
This trial is sponsored by Women and Infants Hospital of Rhode Island, which has 65 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00602355 being conducted?
This trial has 2 study locations across Iowa, Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression, Postpartum
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00602355's enrollment target sits among peer trials
162 6th of 15 higher than 10 of 15 other Depression, Postpartum trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Depression, Postpartum trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Resources, Inspiration, Support and Empowerment (RISE) for Black Pregnant Women
RECRUITING · Phase 2
-
Inhaled Oxytocin and HPA Axis Reactivity
COMPLETED · Phase 2
-
A Study to Assess the Efficacy, Safety, and Tolerability of Oral NORA520 in Adults With Severe Postpartum Depression
COMPLETED · Phase 2
-
IMAGINE: Pilot Trial of a Digital Group Intervention to Prevent Perinatal Depression
RECRUITING · NA
-
A Study to Learn More About How Zuranolone Affects Postpartum Depression Symptoms in Participants Who Took it Within 1 Year After The End of Their Pregnancy
RECRUITING
-
HeartGPS: A Study Exploring the Effects of a Psychological Intervention for Parents and Their Babies After Prenatal Cardiac Diagnosis
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02347111 · 162 participants · Phase 4
Pharmacogenetic Study of Antiarrhythmic Drugs for Atrial Fibrillation
- NCT02610426 · 162 participants
Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Congestive Heart Failure Receiving Therapy for Breast Cancer
- NCT05040711 · 162 participants · NA
mHealth Mindfulness With Patients With Serious Illness and Their Caregivers
- NCT05514717 · 162 participants · Phase 1
A Study of XMT-2056 in Advanced/Recurrent Solid Tumors That Express HER2
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia